Gadolinium & (NSF)
Medical researchers have recently linked a rare disorder, Nephrogenic Fibrosing Dermopathy (NFD), also known as Nephrogenic Systemic Fibrosis (NSF), to the gadolidium contrast dyes used in MRIs (magnetic resonance imaging) and MRAs (magnetic resonance angiography). The gadolidium dyes, which are frequently used to create better contrast to assist physicians in reading the results of these tests, can be highly dangerous to patients with impaired kidney function.
NFD/NFS is a progressive disease associated with the development of excessive scar tissue and/or thick, hardened areas of skin that severely limit joint movement and prevent patients from walking or moving their hands, arms, legs and/or feet. There is no known cure for NFS/NFD, which can be fatal.
The U.S. Food and Drug Administration has requested that manufacturers of gadolidium include a boxed warning on the drug information sheet warning patients with severe kidney insufficiency about the dangers of the gadolidium-based agents. The warning states that patients who have had or are about to have liver transplants, or who have chronic liver disease, are also at risk for developing NFD/NSF if they are experiencing kidney insufficiency of any severity.
At Pogust Braslow & Millrood, we accept cases against the manufacturers of the gadolidium contrast dyes and the doctors who ordered the tests without adequately warning their patients. That is why if you or a loved one has been diagnosed with NFD/NSF as a result of undergoing an MRI or MRA with a gadolidium contrast dye, you should immediately call the attorneys at Pogust Braslow & Millrood, where Protecting Consumers Is Our Primary Goal. We will evaluate your case, explain all of your options, and work to assure that the appropriate parties are held responsible. Just fill out this form, click here to send us an email or call us at (610) 941-4204.
|
